X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (666) 666
Book Review (70) 70
Conference Proceeding (58) 58
Publication (29) 29
Book Chapter (4) 4
Book / eBook (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (380) 380
index medicus (372) 372
female (241) 241
pulmonary hypertension (239) 239
respiratory system (235) 235
male (234) 234
middle aged (205) 205
adult (181) 181
abridged index medicus (173) 173
hypertension, pulmonary - physiopathology (137) 137
hypertension, pulmonary - drug therapy (130) 130
aged (115) 115
cardiac & cardiovascular systems (98) 98
hypertension (95) 95
treatment outcome (92) 92
pulmonary arterial hypertension (88) 88
hypertension, pulmonary - diagnosis (85) 85
survival (84) 84
arterial-hypertension (78) 78
hypertension, pulmonary - etiology (76) 76
diagnosis (71) 71
risk factors (69) 69
critical care medicine (67) 67
therapy (67) 67
care and treatment (62) 62
hemodynamics (58) 58
prognosis (58) 58
retrospective studies (56) 56
research (51) 51
antihypertensive agents - therapeutic use (50) 50
drug therapy (50) 50
pulmonary arteries (47) 47
hypertension, pulmonary - mortality (45) 45
hypertension, pulmonary - therapy (45) 45
medicine, general & internal (45) 45
bosentan (44) 44
disease (43) 43
adolescent (42) 42
life sciences (42) 42
animals (41) 41
hypertension, pulmonary (40) 40
prostacyclin (40) 40
double-blind method (38) 38
chronic disease (37) 37
hypertension, pulmonary - epidemiology (37) 37
prospective studies (36) 36
mortality (34) 34
familial primary pulmonary hypertension (33) 33
follow-up studies (33) 33
mutation (33) 33
surgery (33) 33
peripheral vascular disease (32) 32
hypertension, pulmonary - genetics (31) 31
endothelin (30) 30
endothelin receptor antagonists (30) 30
lung transplantation (30) 30
young adult (30) 30
calcium-channel blockers (29) 29
health aspects (29) 29
pulmonary/respiratory (29) 29
sildenafil (29) 29
time factors (29) 29
analysis (28) 28
case-control studies (28) 28
expression (28) 28
endarterectomy (27) 27
guidelines (27) 27
pulmonary artery - physiopathology (27) 27
double-blind (26) 26
drug therapy, combination (26) 26
epoprostenol (26) 26
heart (26) 26
hypertension, pulmonary - pathology (26) 26
transplantation (26) 26
antihypertensive agents - administration & dosage (25) 25
continuous intravenous epoprostenol (25) 25
hypertension, pulmonary - complications (25) 25
registry (25) 25
cardiovascular (24) 24
patients (24) 24
registries (24) 24
severity of illness index (24) 24
cardiac catheterization (23) 23
clinical trials (23) 23
lung (23) 23
pulmonary embolism (23) 23
aged, 80 and over (22) 22
disease progression (22) 22
france - epidemiology (22) 22
human health and pathology (22) 22
hypertension, pulmonary - surgery (22) 22
rats (22) 22
sulfonamides - therapeutic use (22) 22
bone morphogenetic protein receptors, type ii - genetics (21) 21
algorithms (20) 20
epoprostenol - administration & dosage (20) 20
pulmonary embolism - diagnosis (20) 20
survival rate (20) 20
antihypertensive agents - adverse effects (19) 19
exercise (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 4, pp. 319 - 329
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2014, Volume 63, Issue 25, pp. 2882 - 2883
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 7, pp. 668 - 680
Abstract Background Endothelial cell (EC) dysfunction plays a central role in the pathogenesis of pulmonary arterial hypertension (PAH), promoting... 
Cardiovascular | Internal Medicine | β-blocker | nebivolol | inflammation | endothelial dysfunction | pulmonary hypertension | CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | beta-blocker | RATS | CROSS-TALK | THERAPY | SMOOTH-MUSCLE HYPERPLASIA | ARTERIAL-HYPERTENSION | ANIMAL-MODELS | BLOCKADE | PROGRESSION | Ethanolamines - pharmacology | Benzopyrans - therapeutic use | Cell Proliferation | Rats, Wistar | Metoprolol - pharmacology | Humans | Monocrotaline | Adrenergic beta-1 Receptor Antagonists - pharmacology | Hypertension, Pulmonary - physiopathology | Endothelium, Vascular - drug effects | Male | Adrenergic beta-1 Receptor Antagonists - therapeutic use | Hypertension, Pulmonary - drug therapy | Cell Culture Techniques | Vascular Remodeling - drug effects | Benzopyrans - pharmacology | Disease Models, Animal | Nebivolol | Endothelium, Vascular - physiopathology | Rats | Metoprolol - therapeutic use | Pulmonary Artery - physiopathology | Pulmonary Artery - drug effects | Animals | Myocytes, Smooth Muscle | Cell Communication - drug effects | Endothelium, Vascular - pathology | Ethanolamines - therapeutic use | Hypertension, Pulmonary - pathology | Pulmonary Artery - pathology | Endothelial Cells - drug effects | Heart | Sects | Pulmonary hypertension | Endothelium | Studies | Cell growth | Pulmonary arteries | Mortality | Smooth muscle | Veins & arteries | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2014, Volume 63, Issue 25, p. 2882
  [...]there is no consistent controlled data supporting the use of specific PAH therapy in this setting. [...]the change in clinical classification was... 
Sickle cell anemia | Classification | Sickle cell disease | Pulmonary hypertension
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2014, Volume 63, Issue 25, p. 2882
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2014, Volume 63, Issue 25, pp. 2882 - 2883
Journal Article
Journal of Thoracic and Cardiovascular Surgery, The, ISSN 0022-5223, 2011, Volume 141, Issue 3, pp. 702 - 710
Objective Pulmonary endarterectomy is a curative surgical treatment option for the majority of patients with chronic thromboembolic pulmonary hypertension. The... 
Cardiothoracic Surgery | computed tomography | mPAP | NYHA | mean pulmonary artery pressure | odds ratio | confidence limit | PEA | PVR | chronic thromboembolic pulmonary hypertension | New York Heart Association | PAH | pulmonary endarterectomy | CTEPH | pulmonary vascular resistance | pulmonary arterial hypertension | SURGERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RESPIRATORY SYSTEM | PREDICTORS | THROMBOENDARTERECTOMY | EXPERIENCE | CIRCULATORY ARREST | ENDARTERECTOMY | Endarterectomy - adverse effects | Prospective Studies | Humans | Middle Aged | Hypertension, Pulmonary - physiopathology | Male | Recovery of Function | Young Adult | Exercise Test | Time Factors | Aged, 80 and over | Adult | Female | Registries | Odds Ratio | Endarterectomy - mortality | Clinical Competence | Hypertension, Pulmonary - mortality | Vascular Resistance | Hospital Mortality | Risk Assessment | Europe | Risk Factors | Hypertension, Pulmonary - surgery | Logistic Models | Treatment Outcome | Thromboembolism - mortality | Chi-Square Distribution | Canada | Adolescent | Exercise Tolerance | Survival Analysis | Thromboembolism - complications | Thromboembolism - surgery | Aged | Thromboembolism - physiopathology | Chronic Disease | Hypertension, Pulmonary - etiology | Patient outcomes | Pulmonary hypertension | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 1, pp. 44 - 53
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 26, pp. 2522 - 2533
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2013, Volume 72, Issue 12, pp. 1940 - 1946
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Patients with previously untreated pulmonary arterial hypertension who were randomly assigned to combination therapy with ambrisentan and tadalafil had a... 
INHALED ILOPROST | SURVIVAL | TRIAL | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EPOPROSTENOL | COMBINATION THERAPY | HEART-FAILURE | DOUBLE-BLIND | BOSENTAN | Hypertension, Pulmonary - mortality | Double-Blind Method | Humans | Middle Aged | Risk Factors | Kaplan-Meier Estimate | Hypertension, Pulmonary - physiopathology | Male | Hospitalization | Disease Progression | Tadalafil | Phenylpropionates - therapeutic use | Peptide Fragments - blood | Adult | Female | Phenylpropionates - adverse effects | Aged | Hypertension, Pulmonary - drug therapy | Drug Therapy, Combination | Carbolines - therapeutic use | Carbolines - adverse effects | Natriuretic Peptide, Brain - blood | Pyridazines - adverse effects | Pyridazines - therapeutic use | Symptomatology | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Pulmonary hypertension | Ambrisentan | Hypertension | Edema | Brain natriuretic peptide | Headache | Functional morphology | Pulmonary arteries | Lung diseases | Drug therapy | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus | Drug side effects | Assaigs clínics de medicaments | Efectes secundaris dels medicaments | Hipertensió pulmonar | Drug testing | Life Sciences | Human health and pathology | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal Article